Company Description
Ginkgo Bioworks Holdings (OTC Link: DNABW) is a publicly traded company.
DNABW stock has declined 80.0% over the past year. Shares last traded at $0.0020.
On a trailing twelve-month basis, Ginkgo Bioworks Holdings reported revenue of $170.2M with net income of -$312.8M and diluted earnings per share of $-5.64. The company operates at a net profit margin of -183.8%.
This page provides a comprehensive overview of DNABW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Ginkgo Bioworks Holdings (DNABW) stock last traded at $0.0020. Over the past 12 months, the stock has lost 80.0%.
Latest News
SEC Filings
Ginkgo Bioworks Holdings has filed 5 recent SEC filings, including 2 Form 144, 1 Form SCHEDULE 13G/A, 1 Form 10-K, 1 Form 8-K. The most recent filing was submitted on March 26, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all DNABW SEC filings →
Financial Highlights
Ginkgo Bioworks Holdings generated $170.2M in revenue over the trailing twelve months, operating income reached -$315.3M (-185.3% operating margin), and net income was -$312.8M, reflecting a -183.8% net profit margin. Diluted earnings per share stood at $-5.64. The company generated -$171.1M in operating cash flow. With a current ratio of 4.92, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Ginkgo Bioworks Holdings (DNABW) currently stands at 10.9 thousand shares. Over the past 12 months, short interest has decreased by 72.6%.
Days to Cover History
Days to cover for Ginkgo Bioworks Holdings (DNABW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 4.1 days.